Canada Authorizes Use Of First Plant-Based COVID-19 Vaccine

Canada has become the first country to authorize use of a plant-based COVID-19 vaccine.

Canadian regulators said Thursday Medicago’s two-dose vaccine can be given to adults ages 18 to 64, but said there’s too little data on the shots in people 65 and older.

The decision was based on a study of 24,000 adults that found the vaccine was 71% effective at preventing COVID-19 — although that was before the omicron variant emerged. Side effects were mild, including fever and fatigue.

Medicago uses plants as living factories to grow virus-like particles, which mimic the spike protein that coats the coronavirus. The particles are removed from the plants’ leaves and purified. Another ingredient, an immune-boosting chemical called an adjuvant that is made by British partner GlaxoSmithKline, is added to the shots.

While numerous COVID-19 vaccines have been rolled out around the world, global health authorities are looking to additional candidates in hopes of increasing the worldwide supply.

Quebec City-based Medicago is developing plant-based vaccines against multiple other diseases, and the COVID-19 vaccine may help spur more interest in this new method of medical manufacturing.

What do you think?


Leave a Reply
  1. 116154 316563Its always good to learn ideas like you share for weblog posting. As I just started posting comments for blog and facing problem of lots of rejections. I believe your suggestion would be beneficial for me. I will let you know if its work for me too. 525701

Leave a Reply

Your email address will not be published. Required fields are marked *

SeekInCare® Receives CE Mark For Early Detection Cancer Test

Europe Offers Positive Opinion On ORGOVYX® (relugolix) To Help Treatment of Advanced Prostate Cancer